Empower Cancer Care: Become a CAR T‑Cell Excellence Partner

Prgenix invites medical innovators and healthcare entrepreneurs to co‑launch CAR T‑Cell Excellence Centers in top‑tier hospitals and accredited private labs nationwide, integrating cutting‑edge immunotherapy into traditional oncology services.

Join Us Today Learn More

Establishing CAR T-Cell Excellence Centers Across India

Prgenix is spearheading the expansion of CAR T-cell therapy centers in collaboration with leading hospitals and private laboratories nationwide. This initiative aims to make advanced immunotherapy accessible, offering a transformative approach to cancer treatment.

●

Pioneering Cancer Treatment Accessibility

Modern CAR T-Cell Therapy, a cutting-edge immunotherapy, has shown a 73% success rate in treating B-cell leukemias and lymphomas in India. Developed indigenously, we have reduced costs from ₹3–4 crore to approximately ₹30–40 lakh, making them more accessible to patients nationwide.

●

Collaborative Establishment of Therapy Centers

We are partnering with hospitals and private labs to set up CAR T-Cell therapy centers equipped with state-of-the-art facilities. These centers will provide comprehensive services, from patient evaluation to therapy administration, ensuring adherence to the highest medical standards.

●

Empowering Partners with Sustainable Opportunities

By joining this initiative, partners will play a crucial role in expanding access to life-saving treatments. This collaboration offers a long-term revenue stream through service provision and lead generation, contributing to both community health and business growth all together.

Key Features of CAR T-Cell Excellence Centers

These centers are at the forefront of cancer therapy, offering advanced immunotherapy solutions. Designed to provide cutting-edge treatments, ensuring accessibility, affordability, and high-quality care for patients across India.

Advanced Immunotherapy Infrastructure

Our centers are equipped with state-of-the-art facilities to administer CAR T-cell therapy, a revolutionary treatment for blood cancers like B-cell lymphomas and acute lymphoblastic leukemia. This therapy involves modifying a patient's T-cells to target and destroy cancer cells, offering new hope to patients with relapsed or refractory conditions.

Affordable and Accessible Treatment

By leveraging indigenous developments like NexCAR19, our centers provide CAR T-cell therapy at a fraction of the global cost, making it accessible to a broader patient population. This affordability ensures that more patients can benefit from this life-saving treatment without the burden of exorbitant expenses.

Collaborative Partnerships for Expansion

We invite hospitals, private labs, and healthcare entrepreneurs to partner with us in establishing CAR T-Cell Excellence Centers. Through these collaborations, we aim to expand the reach of advanced cancer treatments, generate leads, and create sustainable, long-term opportunities for our partners while improving patient outcomes nationwide.

Partnership Opportunities

We are seeking dedicated partners to collaborate with us in this transformative journey. By partnering with hospitals, laboratories, and healthcare businesses, you can play a pivotal role in bringing advanced immunotherapy to patients while building a sustainable and impactful enterprise.

Hospitals

Collaborate with us to establish CAR T-Cell therapy units within your hospital infrastructure. This partnership will enhance your oncology services, attract a broader patient base, and position your institution as a leader in cutting-edge cancer treatment. Together, we can provide patients with access to life-saving therapies and improve overall treatment outcomes.

Laboratories

Partnering with Prgenix enables laboratories to extend their services into the realm of advanced cancer therapeutics. By incorporating CAR T-Cell processing and related diagnostics, your lab can become an integral part of the treatment pathway, offering comprehensive solutions and contributing to the advancement of personalized medicine.

Healthcare Businesses

Healthcare entrepreneurs and businesses can collaborate with Prgenix to facilitate the establishment of CAR T-Cell Excellence Centers in various regions. This partnership offers a unique opportunity to be at the forefront of medical innovation, generate leads, and create long-term value by making advanced cancer treatments more accessible to communities across India.

Partner with Prgenix: Lead the Future of Cancer Treatment

Join Prgenix in establishing CAR T-Cell Excellence Centers across India. This partnership offers hospitals, laboratories, and healthcare businesses an opportunity to be at the forefront of advanced cancer therapy. Collaborate with us to bring cutting-edge immunotherapy to patients, expand your service offerings, and contribute to a transformative healthcare initiative.

By partnering with Prgenix, you become an integral part of a pioneering movement to make CAR T-cell therapy more accessible and affordable. Our collaboration ensures that you are equipped with the necessary resources, training, and support to successfully implement this advanced treatment modality. Together, we can enhance patient outcomes and set new standards in cancer care across the nation.

Join Us Today!